Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer

Por Fogelman, David, Cubillo, Antonio, García‐Alfonso, Pilar, Mirón, María Luisa Limón, Nemunaitis, John, Flora, Daniel, Borg, Christophe, Mineur, Laurent, Vieitez, Jose M., Cohn, Allen, Saylors, Gene, Assad, Albert, Switzky, Julie, Zhou, Li, Bendell, Johanna
Publicado no Cancer Med (2018)

Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603)

Por Leon-Ferre, Roberto A, Novotny, Paul J, Wolfe, Eric G, Faubion, Stephanie S, Ruddy, Kathryn J, Flora, Daniel, Dakhil, Christopher S R, Rowland, Kendrith M, Graham, Mark L, Le-Lindqwister, Nguyet, Smith, Thomas J, Loprinzi, Charles L
Publicado no JNCI Cancer Spectr (2019)